Tirzepatide — Research Peptide
Tirzepatide (CAS 2023788-19-2), development code LY3298176, is a synthetic 39-amino-acid peptide supplied as a lyophilized reference material for in-vitro laboratory and analytical research. Each lot is manufactured to a high specification and characterized by independent third-party HPLC for purity, with a lot-matched certificate of analysis published for every vial.
Research context
Tirzepatide is studied in receptor-signaling and analytical research as a dual-receptor reference compound engaging the GIP and GLP-1 receptor systems. Laboratories use it for comparative work alongside single- and triple-receptor compounds, method development, and assay validation. Statements here describe research context only and do not represent any therapeutic use.
Purity and verification
Every lot undergoes independent third-party HPLC analysis before release. The certificate of analysis for the current lot is published on this page and archived at glpxlabs.com/coa.
Specifications
- Sequence: synthetic, verified (39 amino acids)
- Format: lyophilized powder
- Purity: 99%+ by HPLC (see lot COA)
- Storage (lyophilized): −20 °C, freeze, protected from light
- Storage (in solution): 2–8 °C; refrigerate
- Ships: sealed vial with lot number and certificate of analysis
Compliance
This listing is a laboratory reference compound. It is not a drug, supplement, food, or cosmetic, and is not intended for human or veterinary use, diagnostic use, or consumption of any kind. Not evaluated by the FDA. For laboratory research use only.
Also referenced as: tirz peptide, GLP-2, GIP/GLP-1 dual agonist, twincretin, LY3298176.